<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1870-7203</journal-id>
<journal-title><![CDATA[Acta médica Grupo Ángeles]]></journal-title>
<abbrev-journal-title><![CDATA[Acta méd. Grupo Ángeles]]></abbrev-journal-title>
<issn>1870-7203</issn>
<publisher>
<publisher-name><![CDATA[Grupo Ángeles, Servicios de Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1870-72032020000300246</article-id>
<article-id pub-id-type="doi">10.35366/95400</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Prevalencia de hepatitis B y C en donadores de sangre de un hospital privado]]></article-title>
<article-title xml:lang="en"><![CDATA[Prevalence of hepatitis B and C in private hospital blood donors]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ortega Chavarría]]></surname>
<given-names><![CDATA[María José]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ahumada Zavala]]></surname>
<given-names><![CDATA[Silvia Nayeli]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Díaz Greene]]></surname>
<given-names><![CDATA[Enrique]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Rodríguez Weber]]></surname>
<given-names><![CDATA[Federico]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad La Salle Facultad Mexicana de Medicina Hospital Ángeles Pedregal]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Autónoma de México Facultad de Medicina Hospital Ángeles Pedregal]]></institution>
<addr-line><![CDATA[ Ciudad de México]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad La Salle Facultad Mexicana de Medicina Hospital Ángeles Pedregal]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2020</year>
</pub-date>
<volume>18</volume>
<numero>3</numero>
<fpage>246</fpage>
<lpage>250</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1870-72032020000300246&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1870-72032020000300246&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1870-72032020000300246&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen La infección por virus de hepatitis B (VHB) y C (VHC) es un problema de salud pública mundial y un riesgo grave para la medicina transfusional, pues es una causa importante de daño hepático en México.  Objetivo:  Determinar la prevalencia de VHB y VHC en donadores de sangre que acudieron al Hospital Ángeles Pedregal en un lapso de 19 meses.  Material y métodos:  Estudio descriptivo y retrospectivo, realizado del 1 de enero de 2018 al 31 de julio de 2019 en el que se incluyeron a 5,705 donadores.  Resultados:  De los 4,030 casos seleccionados, 30.72% correspondió a mujeres y 69.28% a hombres; se identificaron 22 donaciones altruistas y 4,008 para reposición de hemoderivados. La seroprevalencia global observada en nuestra población fue de 0.27% para VHC y 0.04% para VHB. La infección por VHC tuvo mayor frecuencia en el sexo femenino entre los 45 a 65 años con tres casos.  Conclusiones:  Se encontró una baja prevalencia de infección por VHB y VHC, la cual fue de 0.27 y 0.04% respectivamente, y en nuestra población hubo 5.5 veces más prevalencia de la infección por VHC que por VHB. Probablemente se debió a que la población que acude a donar sangre se encuentra generalmente sana.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Infections caused by hepatitis B virus (HBV) and hepatitis C virus (HCV), are global health issues and a serious risk associated to transfusional medicine; especially being one of the most important causes of liver damage in Mexico.  Objective:  To determine the prevalence of HBV and HCV in blood donors in Hospital Angeles Pedregal in a time lapse of 19 months.  Material and methods:  Retrospective and descriptive study carried out between the 1st of January 2018 and the 31st of July 2019, which included 5,705 donors.  Results:  Of 4,030 selected cases, 30.72% were female and 69.28% were male. We identified 22 altruistic donors and 4,008 for replacement of blood products. Global seroprevalence observed in our population was 0.27% for HCV and 0.04% for HBV. HVC infection was more frequent in females between 45 to 65 years, with three cases.  Conclusions:  A low prevalence of HBV and HVC infection was found, being 0.27% and 0.04%, respectively, HCV prevalence was found to be 5.5 times greater than HBV. These findings are probably explained because blood donors generally are healthy.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Hepatitis B]]></kwd>
<kwd lng="es"><![CDATA[hepatitis C]]></kwd>
<kwd lng="es"><![CDATA[banco de sangre]]></kwd>
<kwd lng="es"><![CDATA[transfusión]]></kwd>
<kwd lng="en"><![CDATA[Hepatitis B]]></kwd>
<kwd lng="en"><![CDATA[hepatitis C]]></kwd>
<kwd lng="en"><![CDATA[blood bank]]></kwd>
<kwd lng="en"><![CDATA[transfusion]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marrón-Peña]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Historia de la transfusión sanguínea]]></article-title>
<source><![CDATA[Rev Mex Anest]]></source>
<year>2017</year>
<volume>40</volume>
<page-range>233-8</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Min]]></surname>
<given-names><![CDATA[HK]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[HO]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Residual risk of transfusion-transmitted infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus in Korea from 2000 through 2010]]></article-title>
<source><![CDATA[BMC Infect Dis]]></source>
<year>2012</year>
<volume>12</volume>
<page-range>160</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schweitzer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Horn]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mikolajczyk]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
<name>
<surname><![CDATA[Krause]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ott]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2015</year>
<volume>386</volume>
<numero>10003</numero>
<issue>10003</issue>
<page-range>1546-55</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Global hepatitis report]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[World Health Organization]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calleja]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Llop]]></surname>
<given-names><![CDATA[HE]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[De la Revilla]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
<name>
<surname><![CDATA[Calvo]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
<name>
<surname><![CDATA[Pons]]></surname>
<given-names><![CDATA[RF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of viral hepatitis (Band C) serological warkers in healthy working population]]></article-title>
<source><![CDATA[Rev Esp Enferm Dig]]></source>
<year>2013</year>
<volume>105</volume>
<page-range>249-54</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cobb]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Pockros]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Vilchez]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Vierling]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[HCV RNA viral load assessments in the era of direct-acting antivirals]]></article-title>
<source><![CDATA[Am J Gastroenterol]]></source>
<year>2013</year>
<volume>108</volume>
<page-range>471-5</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Hepatitis B. Fact Sheet N° 204]]></source>
<year></year>
<publisher-name><![CDATA[[sede web]]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Trépo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[HL]]></given-names>
</name>
<name>
<surname><![CDATA[Lok]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hepatitis B virus infection]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2014</year>
<volume>384</volume>
<page-range>2053-63</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sanchez]]></surname>
<given-names><![CDATA[LV]]></given-names>
</name>
<name>
<surname><![CDATA[Maldonado]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bastidas-Ramirez]]></surname>
<given-names><![CDATA[BE]]></given-names>
</name>
<name>
<surname><![CDATA[Norder]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Panduro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genotypes and S-gene variability of Mexican hepatitis B virus strains]]></article-title>
<source><![CDATA[J Med Virol]]></source>
<year>2002</year>
<volume>68</volume>
<page-range>24-32</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Introduction of hepatitis B vaccine into childhood immunization services: management guidelines, including information for health workers and parents [sede web]]]></source>
<year>2001</year>
<publisher-loc><![CDATA[Geneva ]]></publisher-loc>
<publisher-name><![CDATA[WHO, Department of Vaccines and Biologicals]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Panduro]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Roman]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tanaka]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Kurbanov]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Martinez-Lopez]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Molecular epidemiology of hepatitis C virus genotypes in West Mexico]]></article-title>
<source><![CDATA[Virus Research]]></source>
<year>2010</year>
<volume>151</volume>
<page-range>19-25</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jimenez-Mendez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Uribe-Salas]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Lopez-Guillen]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Cisneros-Garza]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Castañeda-Hernandez]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Distribution of HCV genotypes and HCV RNA viral load in different regions of Mexico]]></article-title>
<source><![CDATA[Ann Hepatol]]></source>
<year>2010</year>
<volume>9</volume>
<page-range>33-9</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gardenier]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kwong]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Olson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Epstein]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Epidemiology, screening, and pretreatment evaluation of the patient with chronic hepatitis C infection]]></article-title>
<source><![CDATA[J Nurse Pract]]></source>
<year>2015</year>
<volume>11</volume>
<page-range>109-15</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Halabe ChJ, Angulo]]></surname>
<given-names><![CDATA[VF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hepatitis viral]]></article-title>
<source><![CDATA[Rev Fac Med UNAM]]></source>
<year>2000</year>
<volume>43</volume>
<page-range>90-100</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rivero-Jiménez]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Transmisión de infecciones virales por la transfusión de sangre]]></article-title>
<source><![CDATA[Rev Cubana Hematol Inmunol Hemoter]]></source>
<year>2006</year>
<volume>22</volume>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Los datos más recientes ponen de relieve la necesidad de actuar urgentemente a nivel mundial contra las hepatitis [sede web]]]></source>
<year></year>
<publisher-loc><![CDATA[Ginebra ]]></publisher-loc>
<publisher-name><![CDATA[Organización Mundial de la Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="book">
<collab>Secretaría de Salud</collab>
<source><![CDATA[Anuario de morbilidad 1984-2015]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Estados Unidos Mexicanos ]]></publisher-loc>
<publisher-name><![CDATA[SUIVE/DGE Secretaría de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<collab>Abbott</collab>
<source><![CDATA[Manual de operaciones del sistema Architect [sede web]]]></source>
<year>2013</year>
<publisher-name><![CDATA[Abbott Laboratories]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<collab>Abbott</collab>
<source><![CDATA[Manual de operaciones del sistema Architect [sede web]]]></source>
<year>2014</year>
<publisher-name><![CDATA[Abbott Laboratories Anti HCV]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="book">
<collab>Abbott</collab>
<source><![CDATA[Manual de operaciones del sistema Architect [sede web]]]></source>
<year>2013</year>
<publisher-name><![CDATA[Abbott Laboratories HBsAg Qualitative II]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<collab>Abbott</collab>
<source><![CDATA[Manual de operaciones del sistema Architect [sede web]]]></source>
<year>2015</year>
<publisher-name><![CDATA[Abbott Laboratories Anti-HBc II]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hernández-Pérez]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Frías-Salcedo]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Del Ángel-Guevara]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Seroprevalencia de anticuerpos contra el virus de la hepatitis C en donadores de sangre del Hospital Central Militar]]></article-title>
<source><![CDATA[Salud Publica Mex]]></source>
<year>1994</year>
<volume>36</volume>
<page-range>538-40</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Álvarez-Muñoz]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Bustamante-Calvillo]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hepatitis B y Delta: prevalencia de marcadores cero epidemiológicos en donadores de sangre voluntarios y su grupo familiar]]></article-title>
<source><![CDATA[Gac Med Mex]]></source>
<year>1991</year>
<volume>127</volume>
<page-range>399-404</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Méndez-Sánchez]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Baptista-González]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez-Gómez]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Bordes-Aznar]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Uribe-Esquivel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de hepatitis B y C en un Hospital de Tercer Nivel de la Ciudad de México]]></article-title>
<source><![CDATA[Salud Pública de México]]></source>
<year>1999</year>
<volume>41</volume>
<page-range>6</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="book">
<collab>Organización Panamericana de la Salud</collab>
<source><![CDATA[Suministro de sangre para transfusiones en los países de Latinoamérica del Caribe]]></source>
<year>2017</year>
<publisher-name><![CDATA[OPS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rivera-López]]></surname>
<given-names><![CDATA[MRF]]></given-names>
</name>
<name>
<surname><![CDATA[Zavala-Méndez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Arenas-Esqueda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de seropositividad para VIH, hepatitis B y C en donadores de sangre]]></article-title>
<source><![CDATA[Gac Méd Méx]]></source>
<year>2004</year>
<volume>140</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>657-60</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Souto-Meiriño]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Simón-Domínguez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pulido-Priego]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández-Pérez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[García-Hernández]]></surname>
<given-names><![CDATA[IC]]></given-names>
</name>
<name>
<surname><![CDATA[Del Río-Chiriboga]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de marcadores para hepatitis A, B y C en un hospital de México]]></article-title>
<source><![CDATA[Salud Publica de México]]></source>
<year>1994</year>
<volume>36</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>257-62</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carreto-Vélez]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Carrada-Bravo]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez-Magdaleno]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Seroprevalencia de VHB, VHC y VIH en donadores de sangre en Irapuato, México]]></article-title>
<source><![CDATA[Salud Pública de México]]></source>
<year>2003</year>
<volume>45</volume>
<numero>^s5</numero>
<issue>^s5</issue>
<supplement>5</supplement>
<page-range>690-3</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
